Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Revenues:
Contract revenue		$ 292,461	$ 33,351	$ 1,137,647
Revenues	$ 214,824	505,288	362,417	1,429,842
Cost of revenues	(204,317)	(363,339)	(326,677)	(1,192,844)
Gross profit	10,507	141,949	35,740	236,998
Operating expenses:
Research and development	2,104,872	2,170,045	3,472,272	4,870,216
General and administrative	915,280	785,776	1,806,720	1,654,443
Research and development expense - milesetone				5,000,000
Total operating expenses	3,020,152	2,955,821	5,278,992	11,524,659
Loss from operations	(3,009,645)	(2,813,872)	(5,243,252)	(11,287,661)
Gain on forgiveness of PPP loan	421,584		421,584
Foreign currency transaction gain/(loss)	17,330	(3,583)	44,583	(26,818)
Interest (expense)/income	(214,750)	2,017	(428,255)	23,964
Research and development incentives	23,671	38,675	81,052	95,525
Net loss before income taxes	(2,761,810)	(2,776,763)	(5,124,288)	(11,194,990)
Income tax benefit	864,742		864,742	836,893
Net loss applicable to common stockholders	$ (1,897,068)	$ (2,776,763)	$ (4,259,546)	$ (10,358,097)
Basic and diluted net loss per share (in Dollars per share)	$ (0.05)	$ (0.10)	$ (0.11)	$ (0.41)
Basic and diluted weighted average common shares outstanding (in Shares)	40,074,275	26,901,781	38,455,210	25,153,350
Grant
Revenues:
Revenues	$ 214,824	$ 212,827	$ 329,066	$ 292,195